Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood–brain barrier disturbance but not with patient survival

Gespeichert in:
Bibliographische Detailangaben
Deutscher übersetzter Titel:Ausdrucksmuster des Wasserkanals Aquaporin-4 in menschlichen Gliomen wird mit Bluthirnschrankenstörung in Zusammenhang gebracht aber nicht mit dem Überleben des Patienten
Autor:Warth, Arne; Simon, Perikles; Capper, David; Goeppert, Benjamin; Tabatabai, Ghazaleh; Herzog, Hajo; Dietz, Klaus; Stubenvoll, Florian; Ajaaj, Rami; Becker, Ralf; Weller, Michael; Meyermann, Richard; Wolburg, Hartwig; Mittelbronn, Michel
Erschienen in:Journal of neuroscience research
Veröffentlicht:85 (2007), 6, S. 1336-1346, Lit.
Format: Literatur (SPOLIT)
Publikationstyp: Zeitschriftenartikel
Medienart: Gedruckte Ressource
Sprache:Englisch
ISSN:0360-4012
DOI:10.1002/jnr.21224
Schlagworte:
Online Zugang:
Erfassungsnummer:PU201010007846
Quelle:BISp

Abstract

Aquaporin-4 (AQP4), the most prominent CNS water channel, is restricted to the glia limitans and astrocytic endfeet. We previously showed the loss of spatial AQP4 expression in glioblastomas and a redistribution across the cell surface. However, opposing AQP4 functions have been described: protective in vasogenic but detrimental in cytotoxic brain edema. Thus, specific AQP4 induction to prevent or reduce vasogenic edema is suggested. To elucidate the AQP4 role in brain tumors, we investigated 189 WHO grade I–IV gliomas by immunohistochemistry and the prognostic significance for patients' survival. In gliomas, a remarkable de novo AQP4 redistribution was observed in comparison with normal CNS tissue. Surprisingly, the highest membraneous staining levels were seen in pilocytic astrocytomas WHO grade I and grade IV glioblastomas, both significantly higher than in WHO grade II astrocytomas. AQP4 up-regulation was associated with brain edema formation; however, no association between survival and WHO grade-dependent AQP4 expression was seen. Hence, AQP4 redistribution may go along with other tumor properties, such as vascular proliferation and resulting blood–brain barrier disturbance, features usually prominent in pilocytic astrocytomas WHO I and glioblastomas WHO grade IV. In summary, our findings question the protective role of AQP4 in vasogenic brain edema. Although AQP4 was associated with brain edema formation, one has to question the suitability of AQP4 induction as a promising approach in vasogenic brain edema prevention and treatment. In addition, our results provide unexpectedly high AQP4 levels in pilocytic astrocytomas and present AQP4 as tumor progression marker in WHO grade II–IV astrocytomas. Verf.-Referat